Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)

Recruiting N/A Interventional Study
Inflammatory Bowel Disease (IBD) Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
72 (estimated)
Sponsor
Raincy Montfermeil Hospital Group · Research network
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older * Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months * Patient is motivated to participate in the Adapted Physical Activity (APA) program * Medical certificate confirming fitness to engage in remote physical activity …
Contacts

Stephane NAHON, Professor

+33141708000

stephane.nahon@ght-gpne.fr

CONTACT